An experimental treatment originally intended to help patients recover from stroke may have beneficial effects for Alzheimer’s disease, according to a recent study.
Laszlo Lorand, PhD, professor emeritus of Cell and Molecular Biology and a distinguished scientist whose career spanned more than 60 years at Northwestern, passed away on December 6.
An experimental genetic inhibitor that could stave off Alzheimer’s disease has unintended consequences, but may represent a target for future drug development, according to a recent study.
Faculty, family and friends gathered at a symposium to honor Robert Goldman, PhD, chair of Cell and Molecular Biology, and his distinguished scientific career.
A new study finds that excessive carbon dioxide in a patient’s bloodstream can lead to a restricted airway, calling into question current clinical practices for patients with chronic obstructive pulmonary disease.
A protein facilitating DNA replication during cell cycle also binds microtubules, findings that could inform more effective cancer treatments, according to a recent study published in the Journal of Cell Biology.
A motor protein called kinesin drives a unique mechanism that ensures correct placement of important proteins and mRNA during development of egg cells.
Treating mice with isradipine, a calcium channel blocker, prevented formation of toxic compounds that can cause Parkinson’s disease symptoms, according to a recent Northwestern Medicine study.
Enhancing autophagy, the system that recycles old or dysfunctional cells, could have therapeutic effects in a variety of aging-related diseases, according to a pair of Northwestern Medicine studies.